Knopp Biosciences LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Knopp Biosciences LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C0488
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Knopp Biosciences LLC (Knopp Biosciences) is a drug discovery and development company that offers medicines for the treatment of inflammatory and neurological diseases. The company’s pipeline products include dexpramipexole and KCNQ2. Its dexpramipexole is an anti-inflammatory therapeutic for moduling white blood cells such as eosinophils and orally bioavailable small molecule, which is used for the treatment of asthma. Knopp Biosciences’ KCNQ2 is an ion channel modulators, which is used for treating epilepsy and neuropathic pain. The company conducts preclinical discovery programs to Phase 2 clinical programs in immunological and neurological disease. It partners with investigators, practitioners and pharmaceutical companies. Knopp Biosciences is headquartered in Pittsburgh, Pennsylvania, the US.

Knopp Biosciences LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Knopp Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Knopp Biosciences LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Knopp Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Knopp Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Knopp Biosciences LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Knopp Biosciences LLC, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Knopp Biosciences Raises USD17.1 Million in Venture Financing 10
Knopp Biosciences Raises USD3 Million in Venture Financing 11
Knopp Biosciences Raises US$15 Million In First Tranche Of Venture Financing 12
Partnerships 13
Albany Molecular Enters Into An Agreement With Knopp Biosciences For Discovery Services 13
Knopp Biosciences LLC – Key Competitors 14
Knopp Biosciences LLC – Key Employees 15
Knopp Biosciences LLC – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Corporate Communications 17
Mar 21, 2017: Knopp Biosciences Announces Election of Biotech Executive Shane Kovacs to Board of Managers 17
Government and Public Interest 18
Oct 23, 2017: Knopp Biosciences Announces Renewal of NIH Blueprint Grant Award for Advancing KCNQ2 Modulators in Epilepsy 18
Product News 19
Nov 30, 2017: New Publication Shows Respiratory Decline Correlated With Disease Progression in People Living With ALS 19
03/21/2017: Knopp Biosciences Announces Election of Biotech Executive Shane Kovacs to Board of Managers 20
03/07/2017: Knopp Biosciences Announces Publication of Eosinophil-Lowering Effects of Dexpramipexole in Multiple Clinical Trials 21
Clinical Trials 22
Feb 16, 2017: Knopp Biosciences Announces NIH Blueprint Grant Award 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Knopp Biosciences LLC, Pharmaceuticals & Healthcare, Key Facts 2
Knopp Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Knopp Biosciences LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Knopp Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Knopp Biosciences LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Knopp Biosciences LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Knopp Biosciences Raises USD17.1 Million in Venture Financing 10
Knopp Biosciences Raises USD3 Million in Venture Financing 11
Knopp Biosciences Raises US$15 Million In First Tranche Of Venture Financing 12
Albany Molecular Enters Into An Agreement With Knopp Biosciences For Discovery Services 13
Knopp Biosciences LLC, Key Competitors 14
Knopp Biosciences LLC, Key Employees 15

List of Figures
Knopp Biosciences LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Knopp Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Knopp Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Knopp Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Knopp Biosciences LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Knopp Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Knopp Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Knopp Biosciences LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Middleby Corporation (MIDD):企業の財務・戦略的SWOT分析
    The Middleby Corporation (MIDD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • NanoString Technologies Inc (NSTG):医療機器:M&Aディール及び事業提携情報
    Summary NanoString Technologies Inc (NanoString) is a developer of life science tools for translational research and molecular diagnostics. The company's products include sprint profiler, Dx analysis system with flex, nCounter MAX analysis system, protein assays, solid tumor assays, gene fusion pane …
  • Beaver Aerospace & Defense, Inc.:企業の戦略・SWOT・財務分析
    Beaver Aerospace & Defense, Inc. - Strategy, SWOT and Corporate Finance Report Summary Beaver Aerospace & Defense, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Ardena Holding NV:製薬・医療:M&Aディール及び事業提携情報
    Summary Ardena Holding NV (Ardena) is a contract development and manufacturing organization. The company offers solid-state chemistry services including polymorph, salt, and co-crystal screening; bio-analytical and formulation development; early-phase clinical supply manufacturing; clinical logistic …
  • Continental Grain Co:企業の戦略的SWOT分析
    Continental Grain Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Aeroports de Paris SA:戦略・SWOT・企業財務分析
    Aeroports de Paris SA - Strategy, SWOT and Corporate Finance Report Summary Aeroports de Paris SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Raya Holding (RAYA):企業の財務・戦略的SWOT分析
    Raya Holding (RAYA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Domino’s Pizza, Inc.:企業の戦略・SWOT・財務情報
    Domino's Pizza, Inc. - Strategy, SWOT and Corporate Finance Report Summary Domino's Pizza, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • CITIC Resources Holdings Limited:企業の戦略・SWOT・財務情報
    CITIC Resources Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary CITIC Resources Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Unicharm Corporation (8113):企業の財務・戦略的SWOT分析
    Unicharm Corporation (8113) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Public Power Corporation SA (PPC):電力:M&Aディール及び事業提携情報
    Summary Public Power Corporation SA (PPC) is a vertically integrated electric utility. It generates and supplies electricity. The company produces energy using lignite, gas, oil, hydro, wind and solar sources. PPC owns power generation projects across the country; holds interests in lignite mines in …
  • China Mengniu Dairy Co Ltd:企業のM&A・事業提携・投資動向
    China Mengniu Dairy Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China Mengniu Dairy Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • TenCate Advanced Armour:企業の戦略・SWOT・財務情報
    TenCate Advanced Armour - Strategy, SWOT and Corporate Finance Report Summary TenCate Advanced Armour - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • CareDx Inc (CDNA):医療機器:M&Aディール及び事業提携情報
    Summary CareDx Inc (CareDx), formerly XDx Inc, is a commercial stage molecular diagnostics company that develops, markets, and delivers diagnostic surveillance solutions. The company offers commercialized testing solution, the AlloMap heart transplant molecular test, is a noninvasive blood test used …
  • Encision Inc (ECIA):企業の財務・戦略的SWOT分析
    Summary Encision Inc (Encision) is a medical device company that manufactures and markets surgical instruments. The company provides laparoscopic monopolar surgical instruments. Its product portfolio includes AEM burn protection systems, AEM instrumentation, cord adapter, inhibit adapter extension, …
  • BrightPath Biotherapeutics Co Ltd (4594):製薬・医療:M&Aディール及び事業提携情報
    Summary BrightPath Biotherapeutics Co Ltd (BrightPath Biotherapeutics), formerly GreenPeptide Co Ltd is a biopharmaceutical company that develops novel cancer immunotherapies. The company offers drug discovery research and early clinical development of cancer immunotherapy; early-phase clinical tria …
  • EL Sewedy Electric Co (SWDY):企業の財務・戦略的SWOT分析
    EL Sewedy Electric Co (SWDY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Petrobras Argentina SA:石油・ガス:M&Aディール及び事業提携情報
    Summary Petrobras Argentina SA (PESA), a subsidiary of Pampa Energia S.A, is an integrated energy company. It carries out the exploration and production of crude oil and natural gas, refining of crude oil, transportation, and marketing of oil and refined products. The company’s product portfolio inc …
  • Sequana SA (SEQ):企業の財務・戦略的SWOT分析
    Sequana SA (SEQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Chiesi USA Inc-製薬・医療分野:企業M&A・提携分析
    Summary Chiesi USA Inc (Chiesi USA), a specialty pharmaceutical company, is a wholly-owned subsidiary of Chiesi Farmaceutici S.p.A. The company researches, develops, produces and commercializes innovative products in the areas such as cardiovascular, respiratory, neonatology, rare disease and specia …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆